Pete Yeung

Stanford Health Care — United States

Medicine · Health Sciences

4h-index174citations38works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(9), Cancer-related gene regulation(8), Monoclonal and Polyclonal Antibodies Research(7), HER2/EGFR in Cancer Research(6), Wnt/β-catenin signaling in development and cancer(6)

Publications38 total

A fiber optic particle plasmon resonance assay for the detection of neurofilament light as a potential early biomarker for diabetic neuropathy
Clinica Chimica Acta·2025
Figures S1-S7 from Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types
2023Open Access
Data from Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types
2023Open Access
Tables S1-S3 from Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types
2023Open Access
Legends for Figures S1-S7 from Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types
2023Open Access
Tables S1-S3 from Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types
2023Open Access
Figures S1-S7 from Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types
2023Open Access
Data from Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types
2023Open Access
Legends for Figures S1-S7 from Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types
2023Open Access
Abstract P193: AMX-818, a novel prodrug HER2-XPAT T-cell engager (TCE) with potent T cell activation, proteolytic cleavage and efficacy in xenograft tumors, and wide safety margins in NHP (Non Human Primate)
Molecular Cancer Therapeutics·2021· 4 cited
Abstract 1824: HER2-XPAT, a novel protease-activatable T-cell engager (TCE) with potent T-cell activation and efficacy in solid tumors and large safety margins in non-human primate (NHP)
Cancer Research·2021· 1 cited
Abstract 3826: GITRL-Fc biomarker and mechanism study: GITRL-Fc reduces Treg frequency in tumors and requires effector function for inhibition of tumor growth
Cancer Research·2018
Abstract 5627: Anti-TIGIT biomarker study: Inhibition of TIGIT induces loss of Tregs from tumors and requires effector function for tumor growth inhibition
Cancer Research·2018· 5 cited
Abstract A030: Biomarker study of vantictumab plus paclitaxel in HER2- breast cancer patients
Molecular Cancer Therapeutics·2018· 1 cited
Abstract 5621: Prevalence of GITR expression and pharmacodynamic (PD) biomarkers in syngeneic tumor models treated by a GITR agonist (GITRL-Fc)
Cancer Research·2017
Abstract 599: Pharmacodynamic biomarkers for anti-TIGIT treatment and prevalence of TIGIT expression in multiple solid tumor types
Cancer Research·2017· 2 cited
Abstract 404: Development of a RSPO3 CLIA-validated assay as a predictive biomarker for response to anti-RSPO3 antibody treatment in patients with solid tumors
Cancer Research·2016· 2 cited
Abstract 4652: Effects of anti-DLL4 treatment on non-small cell lung cancer (NSCLC) human xenograft tumors
Cancer Research·2016· 3 cited
Abstract 3129: Predictive biomarker identification for response to vantictumab (OMP-18R5; anti-Frizzled) using primary patient-derived human pancreatic tumor xenografts
Cancer Research·2016· 3 cited
Abstract P3-07-57: Development of a 6-gene qPCR RUO-validated assay as a predictive biomarker for response of vantictumab (OMP-18R5; anti-frizzled) in HER2- breast cancer patients
Cancer Research·2016· 1 cited
page 1 of 2Next →

Frequent Co-authors

John Lewicki(31), Ann M. Kapoun(30), Austin Gurney(29), Marcus Fischer(24), Belinda Cancilla(22), Wan-Ching Yen(21), Gilbert O’Young(20), Timothy Hoey(19), Fiore Cattaruzza(15), Fumiko Axelrod(12), Lucia Beviglia(12), Cécile Chartier(11), Tim Hoey(11), Cristina Dee-Hoskins(10), Shirley Ma(10), Jalpa Shah(10), May Ji(9), Alayne Brunner(8), Janak Raval(8), Chris T. Bond(8)